Sponsored
Video
Redefining Possibilities in Limb Salvage
03/05/2026
Join Drs. Siah, N’Dandu, and Nagarsheth as they dive into treating high-risk CLTI patients. From redefining what “no-option” truly means, to understanding the role of small artery disease (SAD) and medial arterial calcification (MAC) in decision-making, this discussion highlights both clinical data and real-world experience with LimFlow.
© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Vascular Disease Management or HMP Global, their employees, and affiliates.
Related Content
About Us
Vascular Disease Management™ (VDM), the official media partner of the International Symposium on Endovascular Therapy (ISET) and the Amputation Prevention Symposium (AMP), is a peer-reviewed journal that educates readers on the latest advancements in endovascular treatment strategies.
Learn more about ISET and AMP and register for the events here:
Subscribe Now!
Vascular Disease Management Newsletter




